Top Growth Trends in the Turner Syndrome Market: Key Insights and Opportunities for 2025-2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the market grown in recent years?
The market size for Turner Syndrome has seen a robust growth in recent past. It is estimated to escalate from $2.36 billion in 2024 to $2.55 billion in 2025, marking a compound annual growth rate (CAGR) of 8.0%. The historic growth can be credited to the rise in awareness about women’s health, increased spending on healthcare, expansion of the healthcare sector, heightened awareness and early detection of Turner Syndrome, as well as public initiative campaigns.
How is the market size expected to evolve during the forecast period?
In the coming years, the market size for Turner Syndrome is predicted to witness substantial growth, expanding to $3.42 billion in 2029 with a compound annual growth rate (CAGR) of 7.7%. This projected expansion during the forecast period can be credited to a rise in instances of x chromosome structural abnormalities, an increase in the use of estrogen replacement therapy, greater use of chromosomal microarray analysis (CMA) for diagnosing the disease, a growing female demographic, and a rise in research and development activities. Upcoming trends within the same forecasting period highlight the acceptance of modern technology, launching of new products, advancing growth hormone therapy, an increased demand for hormonal solutions, and the creation of groundbreaking therapeutic techniques.
Get your market report here!
https://www.thebusinessresearchcompany.com/report/turner-syndrome-global-market-report
What are the leading drivers of growth in the market?
The anticipated upswing in the turner syndrome market is attributed to the swelling female populace. This refers to the aggregate of females inhabiting a specific locale or globally at a defined period. This surge in the female population is motivated by factors such as long life expectancy, advanced healthcare, and demographic transition. Treatments for Turner syndrome aid the female populace by offering therapies like growth hormone to amplify stature, estrogen replacement to usher in puberty and sustain bone health, along with comprehensive medical care to handle associated symptoms, thereby promoting physical growth, reproductive wellness and overall health. For example, data from the Census Bureau, a government body in the US, indicated that the female population in the United States stood at roughly 168 million in July 2022 as of March 2024. In addition, there was a count of approximately 1.9 million females aged 85 and above. Moreover, as per a report released by CEIC Data, a financial service firm in the UK, in December 2022, the total females in the age bracket of 15-64 were 2,951,856 in 2022, an upswing from 2,940,645 in 2021. Hence, the burgeoning female population is fuelling the progress of the Turner syndrome market.
What are the market segments in the industry?
The turner syndrome market covered in this report is segmented –
1) By Type: Classical Turner Syndrome, Mosaic Turner syndrome
2) By Therapy Type: Growth Hormone Therapy, Estrogen And Progesteron, Replacement Therapy, Other Therapy Types
3) By Drug Type: Norditropin, Oxandrolone, Humatrope, Somatropin, Oxandrin, Genotropin, Nutropin, Zomacton
4) By End-User: Hospitals, Homecare, Specialty Clinics, Surgical Centres, Other End-Users
Subsegments:
1) By Classical Turner Syndrome: Complete Monosomy X, X Chromosome Deletion
2) By Mosaic Turner Syndrome: Mosaicism With 45,X/46,XX Karyotype, Mosaicism With 45,X/46,XY Karyotype
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21310&type=smp
Which leading companies are shaping the growth of the market?
Major companies operating in the turner syndrome market are Pfizer Inc., Sanofi SA, AstraZeneca Plc, Abbott Laboratories, Novartis AG, LG Chem Ltd., Eli Lilly and Company, Novo Nordisk, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Genentech Inc., Ipsen Pharma, Ferring Pharmaceutical, BioMarin Pharmaceutical Inc., United Imaging Healthcare Co. Ltd., Daewoong Pharmaceutical Co. Ltd., OPKO Health Inc., Hanmi Pharmaceutical Co. Ltd., Dong-A ST Co. Ltd., GeneScience Pharmaceuticals Co. Ltd., Ascendis Pharma, AnkeBio Co. Ltd., Biopartners Inc., Kexing Biopharm Co. Ltd.
What emerging trends are influencing the growth of the market?
Leading firms in the turner syndrome market are currently prioritizing clinical trials to develop cutting-edge products like pediatric growth hormone medications. These synthetic or recombinant hormone treatments are fast becoming pivotal resources to boost growth, enhance height outcomes, and foster comprehensive development in kids affected with growth hormone deficiencies or growth-related disorders. In this context, we can refer to the positive outcomes from the Phase 2 New InsiGHTS trial of TransCon hGH (lonapegsomatropin) conducted by Denmark-based biopharmaceutical company, Ascendis Pharma A/S, in December 2024. The trial, conducted on 49 Turner syndrome afflicted prepubertal kids aged between 1 and 10, showed promising improvement in growth across all three initial dose cohorts, equalling the results of daily somatropin. These encouraging results open up potential avenues for expanding the market reach of TransCon hGH, offering a safety profile and efficacy on par with daily treatments.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21310
Which geographic areas are influencing the growth of the market?
North America was the largest region in the turner syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the turner syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Diffuse Large B-Cell Lymphoma Therapeutics Global Market Report 2025
Follicular Lymphoma Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/follicular-lymphoma-treatment-global-market-report
Mantle Cell Lymphoma Therapeutics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
